| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 631,815 | 592,854 | 654,282 | 782,601 | | Cost of Revenue | 501,909 | 486,170 | 533,993 | 620,586 | | | Gross Profit | 129,906 | 106,684 | 120,289 | 162,015 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 110,167 | 108,249 | 107,012 | 114,825 | | Non Recurring | 11,307 | 35,665 | 43,610 | 7,783 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,432 | (37,230) | (30,333) | 39,407 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,761) | 3,361 | (17,179) | 1,857 | | Earnings Before Interest And Taxes | (13,190) | (33,869) | (47,512) | 39,837 | | Interest Expense | (14,720) | 14,720 | 17,082 | 17,532 | | Income Before Tax | 1,530 | (48,589) | (64,594) | 22,305 | | Income Tax Expense | 9,130 | 4,872 | (1,072) | 6,367 | | Minority Interest |
-
|
-
| (45) | (102) | | | | Net Income From Continuing Ops | (7,626) | (53,461) | (63,567) | 15,836 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| (555) | (835) | (409) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,946) | (54,016) | (64,402) | 15,427 | | Preferred Stock And Other Adjustments | (42) | 42 |
-
|
-
| | | Net Income Applicable To Common Shares | ($7,988) | ($53,974) | ($64,402) | $15,427 |
|
0.02% Nasdaq 0.00%
Income Statement
